Who May Be A Candidate For Sublocade?

Sublocade is specifically approved for adults diagnosed with moderate to severe opioid use disorder. However, not every patient can begin treatment immediately. According to clinical guidelines, candidates typically must first start treatment with an oral or transmucosal form of buprenorphine and demonstrate tolerance to the medication.

In general, ideal candidates for Sublocade include individuals who:

● Have a confirmed diagnosis of opioid use disorder
● Are currently stabilized on buprenorphine (or have completed an initial induction phase)
● Are committed to ongoing recovery, including counseling or behavioral therapy
● Prefer a long-acting option instead of daily medication

At MAPS for Recovery, Dr. Lynn E. Lytton emphasizes a structured approach, ensuring patients meet both medical and behavioral readiness criteria before starting Sublocade.

Sublocade is used exclusively for the treatment of opioid use disorder—not for general pain management. It is designed to help individuals recovering from dependence on opioids such as heroin, fentanyl, or prescription pain medications.

Opioid use disorder is a complex condition that affects both brain chemistry and behavior. Sublocade works by delivering a steady dose of buprenorphine over the course of a month, helping to stabilize brain receptors involved in addiction.

At MAPS for Recovery, Dr. Lynn E. Lytton integrates Sublocade into a broader treatment plan that may include therapy, relapse prevention strategies, and long-term recovery support—addressing both the physical and psychological aspects of addiction.

Yes, one of the primary benefits of Sublocade is its ability to reduce cravings and withdrawal symptoms. Buprenorphine, the active ingredient, partially activates opioid receptors in the brain. This helps minimize withdrawal discomfort while blocking the euphoric effects of other opioids.

Because Sublocade is administered as a once-monthly injection, it provides consistent medication levels throughout the body. This eliminates the peaks and valleys associated with daily dosing and reduces the risk of missed doses.

Patients at MAPS for Recovery often find that this stability allows them to focus more on therapy, rebuilding routines, and maintaining long-term sobriety rather than managing daily medication schedules.

Sublocade can be an effective option for long-term recovery, particularly for individuals who benefit from structured, consistent treatment. Its extended-release formulation supports ongoing stability and reduces the likelihood of relapse by maintaining therapeutic medication levels over time.

Many patients choose Sublocade because:

● It removes the need for daily medication adherence
● It reduces the risk of misuse or diversion
● It supports a more discreet recovery process
● It aligns with long-term treatment goals

At MAPS for Recovery, Dr. Lynn E. Lytton works closely with patients to determine how long Sublocade should be part of their recovery plan. Some individuals use it as a transitional tool, while others benefit from longer-term maintenance depending on their clinical needs.

At MAPS for Recovery, Dr. Lynn E. Lytton follows a comprehensive and individualized evaluation process to determine whether a patient is a good candidate for Sublocade. This assessment goes beyond basic eligibility and focuses on the whole person.

Key factors considered include:

● Medical history: Including prior substance use and any co-occurring conditions
● Current treatment status: Whether the patient has started or stabilized on buprenorphine
● Severity of opioid use disorder: Including risk of relapse or overdose
● Lifestyle and preferences: Such as the ability to adhere to daily medication versus monthly injections
● Recovery goals: Short-term stabilization vs. long-term maintenance

Clinical guidelines also suggest that Sublocade is particularly beneficial for individuals at higher risk of relapse, those who struggle with daily medication adherence, or those who prefer a more structured treatment option. Dr. Lynn E. Lytton and her team at MAPS for Recovery prioritize patient safety, comfort, and long-term success. Every treatment plan is tailored to ensure that Sublocade is not only appropriate but also aligned with the patient’s overall recovery strategy. For more information, contact us or book an appointment online. We are conveniently located at 13809 Research Blvd, Stu 500 Austin, Texas 78750. We serve patients from Austin TX, Georgetown TX, Leander TX, Jonestown TX, Cedar Park TX, Round Rock TX, Rollingwood, TX, Bluff Springs TX, Del Valle TX, and surrounding areas.